Laboratory Animal Bite Anaphylaxis: A National Survey: Part 2: Treatment Protocols.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 28609353.
- Also identified by DOI 10.1097/JOM.0000000000001063.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study documents current treatment protocols for laboratory animal bite anaphylaxis in the United States. An online survey was e-mailed to designated institutional officials at laboratory animal facilities identified by the National Institutes of Health Office of Laboratory Animal Welfare. One hundred eighty-nine organizations responded to the question of whether they had a treatment protocol with 32% indicating that they had a protocol. Having a case of anaphylaxis increased the likelihood of having a protocol (61%). Of those with a protocol, 58% included treatment with injectable epinephrine, if clinically indicated. Among all respondents, only 14% reported keeping injectable epinephrine at the location where animal work is performed. A minority of responding organizations had protocols in place to address laboratory animal bite anaphylaxis. Organizations with workers at risk should consider implementing a protocol for assessment and treatment.
Medical subject headings
- Anaphylaxis
- Animals, Laboratory
- Bites and Stings
- Occupational Injuries
- Organizational Policy